- Home
- / China Medical System
China Medical System
Stock Price
$8.3
2024-10-29
Market Capitalization
$18.8 B
2024-10-29
Revenue
¥8.2 B
FY, 2025
China Medical System Summary
Company Summary
- Overview
- China Medical System (CMS) is a company that manufactures pharmaceutical products. It offers Plendil for the treatment of hypertension, XinHuoSu for the treatment of acute heart failure, Salofalk for treating Ulcerative Colitis, and other products. The company provides products for cardiovascular, dermatology, Opthalmology, and consumer healthcare.
- Type
- Public
- Status
- Active
- Founded
- 1995
- HQ
- George Town, KY | view all locations
- Website
- https://web.cms.net.cn
- Sectors
Table of Contents
LocationsView all
1 location detected
George Town, George Town HQ
Cayman Islands
7JR7+VR6, S Church St
China Medical System Financials
Summary Financials
- Revenue (FY, 2025)
- ¥8.2B
- Gross profit (FY, 2025)
- ¥6.2B
- Net income (FY, 2025)
- ¥1.4B
- Cash (FY, 2025)
- ¥2.7B
- EBIT (FY, 2025)
- ¥1.9B
- Enterprise value
- $16.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026